The United States Patent and Trademark Office (USPTO) has updated the status of the trademark application TM99165165, associated with the mark LITIMIC. This application covers a broad range of pharmaceutical preparations, including vaccines, anti-infectives, and treatments for numerous diseases and disorders affecting various bodily systems. The status change is effective March 22, 2026.

This update signifies a procedural step in the trademark application process. For companies involved in pharmaceuticals, this indicates a potential new entrant or a change in the branding landscape for specific therapeutic areas. No immediate compliance actions are required for other entities, but monitoring trademark filings is advisable for competitive intelligence and potential future conflicts.